Pathological retrograde signaling in ALS
Pathological retrograde signaling in ALS
批准号:
7916362
负责人:
Robert G Kalb
金额:
$24.43万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2012-08-31
关键词:
AddressAmyotrophic Lateral SclerosisAxonBindingBiologicalBiological ModelsBrain-Derived Neurotrophic FactorCandidate Disease GeneCell Surface ReceptorsCell SurvivalCell membraneCellsClinical TrialsControl GroupsDendritesDisease ProgressionDistalDoseEndocytosisEngineeringEventFamilial Motor Neuron DiseaseForced expiratory volume functionGenesGoalsGrowthIn VitroIndividualLesionLightLocationMeasuresMicroarray AnalysisMolecularMotor Neuron DiseaseMotor NeuronsMutateNatureNeuritesNeurodegenerative DisordersNeurotrophic Tyrosine Kinase Receptor Type 2PathogenesisPatientsPredispositionPresynaptic TerminalsProcessPropertyProtein BiosynthesisProteinsReceptor ActivationRodent ModelSignal TransductionSurfaceSystemTestingToxic effecthigh riskin vivoinsightinterestmutantneuronal cell bodynovelpatient assistancepublic health relevanceresearch studyretrograde transport
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The activation of the receptor TrkB by brain derived neurotrophic factor (BDNF) supports the survival of pure motor neurons in vitro and rescues motor neurons in some in vivo lesion paradigms. In addition, growing motor neurons in the presence of BDNF will induce a state of vulnerability to toxic insults. For example, when motor neurons are grown in a cocktail of trophic factors including BDNF, TrkB antagonism (genetically or pharmacologically) protects against excitotoxic and proteotoxic insults relevant to ALS. The mechanism of this adverse property of BDNF-TrkB signaling is incompletely understood but is known to depend on de novo protein synthesis. TrkB is displayed on the plasma membrane of axons, dendrites and the cell soma. Using Campenot compartment culture system, we find that activation of Trk in the axo- dendritic domain (not the cell soma) renders motor neurons vulnerable to toxic insult. Since axons and dendrites differ dramatically at the cell and molecular biological level it is essential to determine from which compartment the vulnerability signal originates. In Specific aim #1, we will generate chimeric TrkB proteins that target its expression to either the axonal or the dendritic domain. Next we will determine in which compartment TrkB activation leads to vulernability mutant SOD toxicity. The repertoire of mRNAs in the axo-dendritic domain is at least partially distinct from those present in the cell body. A microarray analysis provides us with candidate molecules that might underlie the molecular mechanism of the effect of BDNF. In Specific aim #2, we will manipulate the expression strong candidate molecules and determine if they abrogate the capacity of BDNF to render motor neurons vulnerable to insult. These high-risk-high gain experiments will provide novel insight into the pathogenesis of motor neuron disease.
PUBLIC HEALTH RELEVANCE: Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease in which motor neurons die and individuals become progressively weak. In rodent model systems, activation of a cell surface receptor called TrkB can make motor neurons vulnerable to insults relevant to ALS. In this proposal we will determine where on the surface of a motor neuron (e.g., axons versus dendrites) activation of TrkB renders them vulnerable to insult. Next we will study the importance of candidate molecules in axons or dendrites that undergo new synthesis upon activation of TrkB. These studies will bring mechanistic insight into why motor neurons die in ALS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining mechanisms underlying C9orf72-associated frontotemporal dementia with C. elegans and mammalian models
-
批准号:10552038
-
项目类别:
-
资助金额:$74.57万
-
财政年份:2022
-
负责人:Robert G Kalb
-
依托单位:
Defining mechanisms underlying C9orf72-associated frontotemporal dementia with C. elegans and mammalian models
-
批准号:10342721
-
项目类别:
-
资助金额:$76.69万
-
财政年份:2022
-
负责人:Robert G Kalb
-
依托单位:
RAD23 Control of ALS phenotypes
-
批准号:10406184
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2021
-
负责人:Robert G Kalb
-
依托单位:
RAD23 Control of ALS phenotypes
-
批准号:10617853
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2021
-
负责人:Robert G Kalb
-
依托单位:
RAD23 Control of ALS phenotypes
-
批准号:10274489
-
项目类别:
-
资助金额:$39.88万
-
财政年份:2021
-
负责人:Robert G Kalb
-
依托单位:
AMPK, metabolism and ALS
-
批准号:9621133
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2018
-
负责人:Robert G Kalb
-
依托单位:
Cytohesins, ARF GTP'ases and Neurodegeneration
-
批准号:9605921
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2017
-
负责人:Robert G Kalb
-
依托单位:
AMPK, metabolism and ALS
-
批准号:9244083
-
项目类别:
-
资助金额:$38.69万
-
财政年份:2016
-
负责人:Robert G Kalb
-
依托单位:
AMPK, metabolism and ALS
-
批准号:9114785
-
项目类别:
-
资助金额:$49.29万
-
财政年份:2016
-
负责人:Robert G Kalb
-
依托单位:
Cytohesins, ARF GTP'ases and Neurodegeneration
-
批准号:9275554
-
项目类别:
-
资助金额:$12.6万
-
财政年份:2016
-
负责人:Robert G Kalb
-
依托单位:
ERAD genes that suppress neurodegeneration
-
批准号:8821999
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2014
-
负责人:Robert G Kalb
-
依托单位:
Identification of the endogenous ligand of SAP97 PDZ3
-
批准号:8606782
-
项目类别:
-
资助金额:$20.73万
-
财政年份:2013
-
负责人:Robert G Kalb
-
依托单位:
Identification of the endogenous ligand of SAP97 PDZ3
-
批准号:8507422
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2013
-
负责人:Robert G Kalb
-
依托单位:
Spatio-temporal control of FOXO3
-
批准号:8307681
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2012
-
负责人:Robert G Kalb
-
依托单位:
Spatio-temporal control of FOXO3
-
批准号:8445215
-
项目类别:
-
资助金额:$19.79万
-
财政年份:2012
-
负责人:Robert G Kalb
-
依托单位:
Energy Balance and Neurodegenerative Disease
-
批准号:8371374
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2012
-
负责人:Robert G Kalb
-
依托单位:
Energy Balance and Neurodegenerative Disease
-
批准号:8465927
-
项目类别:
-
资助金额:$24.25万
-
财政年份:2012
-
负责人:Robert G Kalb
-
依托单位:
Abnormal Energy Homeostasis in ALS
-
批准号:7529077
-
项目类别:
-
资助金额:$17.99万
-
财政年份:2008
-
负责人:Robert G Kalb
-
依托单位:
Trophic Factor Signaling and Motor Neuron Death
-
批准号:8787803
-
项目类别:
-
资助金额:$36.64万
-
财政年份:2006
-
负责人:Robert G Kalb
-
依托单位:
Trophic Factor Signaling and Motor Neuron Death
-
批准号:8603291
-
项目类别:
-
资助金额:$36.27万
-
财政年份:2006
-
负责人:Robert G Kalb
-
依托单位:
海外基金